AstraZeneca named to 2013 Working Mother 100 Best Companies

Wednesday, 25 September 2013

AstraZeneca was named to Working Mother magazine’s '100 Best Companies' list for the 12th consecutive year. Rising 14 spots from 2006, AstraZeneca is ranked number 12 out of 100. AstraZeneca has been recognized for the company’s commitment to helping employees manage the demands of work and personal life.

AstraZeneca was highly rated for its childcare programs, ranking 2nd out of all 100 companies for childcare opportunities. The AstraZeneca Child Development Center, accredited by the National Association for the Education of Young Children, serves up to 346 children providing the highest quality educational and developmental programs, better staff-to-child ratios than required by the state, and the ability for parents to visit any time.

“This award truly recognizes AstraZeneca for its continued commitment to supporting our employees and their families by offering programs work-life effectiveness, child-care and diversity programs,” said Laura Mably, Vice President of AstraZeneca US HR.

Working Mother also highlighted the work AstraZeneca is doing to promote a healthy workforce through free nutrition counseling, wellness coaching, medical screenings and an on-site fitness center offering spin, yoga and other exercise classes.

Additional programs AstraZeneca offers that contribute to a supportive working culture include:

  • Flexible work arrangements.
  • Work/Life resource and employee assistance program providing confidential, personal support, resources and referrals to help solve personal and work-related challenges.
  • Career development and mentoring programs, including support for women’s advancement.
  • Diverse employee network groups, including a working parents network and an eldercare group.
  • Childcare and eldercare resources, services and discounts.

Profiles of the Working Mother 100 Best Companies will be in the October/November issue of Working Mother magazine and online at


About AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit:


Media Inquiries

Michele Meixell +1 302 885 2677
Alisha Martin +1 302 885 5483